Waverley Pharma Inc.
WAVE.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -200.10K | -252.00K | -195.90K | -980.20K | -231.10K |
| Total Depreciation and Amortization | 2.40K | -- | -- | 59.20K | 60.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.30K | 21.90K | 23.20K | 695.60K | 26.10K |
| Change in Net Operating Assets | 210.70K | 47.20K | 89.60K | -129.10K | -54.70K |
| Cash from Operations | 34.30K | -182.90K | -83.20K | -354.60K | -199.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -448.50K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -448.50K | -- | -- | -- | -- |
| Total Debt Issued | 749.10K | 251.40K | 113.20K | 503.90K | 251.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 549.20K | 183.70K | 84.00K | 370.40K | 187.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.00K | 800.00 | 800.00 | 15.80K | -12.10K |